SHARE

July 21, 2022

EEOC Potentially Limits Employer's Right to Mandate COVID-19 Testing

You've Reached Your
Free Article Limit This Month
Register for free to get unlimited access to all Law.com OnPractice content.
Register Now

On July 12, 2022, the US Equal Employment Opportunity Commission (EEOC) revised its guidance on compliance with disability discrimination law during the COVID-19 pandemic. While previous guidance, initially published on December 14, 2021, provided that COVID-19 viral testing was permissible for on-site employees and did not run afoul of the Americans with Disability Act (ADA) due to health and safety priorities of the pandemic, the recent EEOC updates now only permit screening and viral testing measures when such measures are job-related and consistent with business necessity, holding COVID-19 testing to the same standard as other workplace medical tests. The July 12 update "makes clear that going forward employers will need to assess whether current pandemic circumstances and individual workplace circumstances justify viral screening of employees to prevent workplace transmission of COVID-19," the EEOC said.

IN DEPTH


The updated EEOC guidance explains that to remain in compliance with the ADA, any viral testing program, which is considered a medical examination under the ADA, must be "job-related and consistent with business necessity." This is consistent with the EEOC's pre-pandemic guidance about subjecting employees to medical examinations. The EEOC's latest guidance clarifies that implementing viral testing to screen employees before they return to the office after exposure to or contracting COVID-19 will typically meet the "business necessity" requirement, as long as testing procedures are consistent with the current guidance from the US Occupational Safety and Health Administration (OSHA), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and other public health authorities. Additionally, the EEOC lists certain factors employers may consider, including:

  • The level of community transmission;
  • The vaccination status of employees;
  • The accuracy and speed of obtaining test results;
  • The possibility of breakthrough infections among vaccinated employees;
  • The transmissibility of the current COVID-19 variant;
  • The possibility of severe illness resulting from infection with the current variant;
  • The nature of contacts employees may have in the workplace or any other location where they are required to work (e.g., assisted living or retirement facilities, hospitals or other medical centers with a high number of medically vulnerable individuals); and
  • The impact on operations if an employee infected with COVID-19 is present in the workplace.

Employers must also consider reasonable accommodation obligations, if applicable, before making any decisions.

SCOPE OF THE UPDATED GUIDANCE

Importantly, the updated guidance pertains only to viral testing. Employers remain prohibited from requiring antibody tests in order for employees to return to work. The EEOC's guidance does not distinguish between at-home and lab-verified results.

TAKEAWAYS

After this most recent update to the EEOC guidance on COVID-19, employers will need to reevaluate any mandated viral testing policies before employees return to work, unless these policies are implemented in response to OSHA, CDC or other similar obligations. Employers also need to be mindful of their obligations under relevant state or local law; for employers with a multi-location workforce, they may need to implement various testing requirements based on applicable law and community transmission rates.

Moreover, the updates prompt employers to make individual assessments under the ADA and take certain factors into account when carrying out this fact-based analysis. Employers should contact their McDermott lawyer to discuss how the EEOC's "business necessity" analysis may be implicated with ongoing COVID-19 waves.

Laura Sabia, a Summer Associate in the Boston office, also contributed to this article.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From McDermott Will & Emery

Trending in Telehealth: January 9 - 16, 2023

By Amanda Enyeart McDermott Will & Emery January 19 , 2023

Trending in Telehealth is a new weekly series from the McDermott Digital Health team where we track telehealth regulatory and legislative activity.

That Stings: Consent to Jurisdiction Must Be Effective at Filing to Invoke Fed. R. Civ. P. 4(k)(2)

By Joshua Revilla McDermott Will & Emery January 19 , 2023

The US Court of Appeals for the Federal Circuit, on petition for writ of mandamus, vacated the district court’s transfer order and remanded the transfer to be considered under the clarified parameters of Fed. R. Civ. P. 4(k)(2) and 28 U.S.C. § 1404.

Absent Expressed Rationale of Obviousness, Federal Circuit Calls for Do-Over

By Anisa Noorassa McDermott Will & Emery January 19 , 2023

The US Court of Appeals for the Federal Circuit reversed a ruling by the Patent Trial & Appeal Board (Board) where, on appeal, the US Patent & Trademark Office’s (PTO) rationale for sustaining the Board’s obviousness rejection did not reflect “the reasoning or findings the Board actually invoked.”

More From Employment Law

5 Trends to Watch in 2023 in Texas Health Care

By Joseph F. Coniglio Greenberg Traurig January 19 , 2023

Observers believe that the COVID-19-related public health emergency (PHE) will be extended until April of 2023.

Trending in Telehealth: January 9 - 16, 2023

By Amanda Enyeart McDermott Will & Emery January 19 , 2023

Trending in Telehealth is a new weekly series from the McDermott Digital Health team where we track telehealth regulatory and legislative activity.

This Week in 340B: January 9 - 16, 2023

By Emily Jane Cook McDermott Will & Emery January 18 , 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country.

Featured Stories
Closeclose
Search
Menu

Working...